In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone.

In vitro activity of LB20304 against 1,231 clinical isolates was evaluated and compared with those of ciprofloxacin, sparfloxacin, lomefloxacin, and ofloxacin. LB20304 demonstrated the most potent activity against gram-positive bacteria. It was 32- to 64-fold more active than ciprofloxacin against m...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Oh, J I, Paek, K S, Ahn, M J, Kim, M Y, Hong, C Y, Kim, I C, Kwak, J H
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1996
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163372/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8726042/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.6.1564
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!